[Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder].
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D001283:Atrioventricular Node / Q000187:drug effects; D002036:Bundle of His / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D006334:Heart Function Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D016293:Moricizine / Q000031:analogs & derivatives*; D010640:Phenothiazines / Q000627:therapeutic use*; D011690:Purkinje Fibers / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; C027240:diethylamino-ethmozine; D016293:Moricizine
Vliianie novogo antiaritmicheskogo preparata étatsizina (dietilaminovogo analoga étmozina) na funktsional'noe sostoianie provodiashcheĭ sistemy serdtsa u bol'nykh s razlichnymi formami narusheniia ritma serdtsa.